GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide act on appetite regulation, satiety signaling, and gastric emptying
The injection site does not significantly influence dry mouth severity, whether you inject in the stomach , thigh , or arm
Obaid, G., Jin, W., Bano, S., Kessel, D
Studies of brand-name semaglutide show that stopping treatment typically leads to weight regainwhich is why we focus on body composition from day one
The important thing is paying attention to how your body reacts and being prepared with plenty of extra water, loose, light clothing, a hat, sunscreen, and access to shade
Trading those for a possible cancer benefit that has not yet been shown in a randomized trial is not a calculation we are comfortable recommending